A new China Healthcare Equity fund has been launched by Invesco to capture the opportunities in the country's expanding healthcare sector fuelled by "robust growth" in spending.
Hong Kong-based senior fund manager Chris Liu will invest primarily in Chinese healthcare companies mainly listed on the Shanghai or Shenzhen Stock Exchanges and traded via Stock Connect, holding between 30 and 40 stocks in the portfolio. Invesco said the fund's growth-orientated strategy will see the manager focus on healthcare mid-cap stocks, investing in Chinese companies with "sustainable growth potential" that fall into five healthcare subsectors, including medical devices, contract research organisations/contract development and manufacturing organisations, drug manufacturers, medi...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
